Home › NDC Lookup › RxCUI directory › RxCUI 2107621

Levodopa 42 MG Inhalation Powder [Inbrija] — RxCUI 2107621

RxNorm drug concept · Semantic branded drug
RxCUI 2107621 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2107621
Official nameLevodopa 42 MG Inhalation Powder [Inbrija]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asInbrija 42 MG Inhalation Powder; Inbrija 42 MG Inhalation Powder Capsule; L-DOPA 42 MG Inhalation Powder [Inbrija]
FDA products mapped2
Package NDCs mapped9
Reported Medicaid activity (SDUD)194 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levodopa Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • An OFF episode is when your regular oral Parkinson's medication temporarily stops working as well as it should. You might notice your symptoms — stiffness, slowness, tremor, or dif...
  • What exactly is an OFF episode, and how will I know when I'm having one?
  • Yes, absolutely — Inbrija is not a replacement for your regular carbidopa/levodopa tablets or capsules. It only works when used alongside your oral medication. Think of it as a res...
  • Do I still take my regular Parkinson's pills if I use Inbrija?
📖 Read our full Levodopa Oral Inhalation guide →

🕸️ Concept Web — How Levodopa 42 MG Inhalation Powder [Inbrija] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levodopa 42 MG Inhalation Powder [Inbrija] RxCUI 2107621

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levodopa 6375
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Inbrija 2107617
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levodopa Inhalation Powder 2108239
    • Levodopa Inhalant Product 2107614
    • Levodopa Inhalation Powder [Inbrija] 2108241
    • Inbrija Inhalant Product 2107620
    • Inhalation Powder 317000
    • Inhalant Product 1151123
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levodopa 42 MG Inhalation Powder SCD · 2107616
  • Levodopa 42 MG SCDC · 2107613
  • Levodopa Inhalation Powder SCDF · 2108239
  • Levodopa Inhalant Product SCDG · 2107614

Brand-Name Concepts

  • Levodopa 42 MG [Inbrija] SBDC · 2107618
  • Levodopa Inhalation Powder [Inbrija] SBDF · 2108241
  • Inbrija Inhalant Product SBDG · 2107620
  • Inbrija BN · 2107617

📦 FDA Products & Package NDCs

2 products · 9 package NDCs
9 package NDCs map to RxCUI 2107621 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00259-6142-16 4 BLISTER PACK in 1 CARTON (0259-6142-16) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
00259-6142-32 8 BLISTER PACK in 1 CARTON (0259-6142-32) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
00259-6142-60 15 BLISTER PACK in 1 CARTON (0259-6142-60) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
10144-0342-04 1 BLISTER PACK in 1 CARTON (10144-342-04) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2019-08-29
10144-0342-12 3 BLISTER PACK in 1 CARTON (10144-342-12) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2019-08-29
10144-0342-16 4 BLISTER PACK in 1 CARTON (10144-342-16) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
10144-0342-32 8 BLISTER PACK in 1 CARTON (10144-342-32) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
10144-0342-60 15 BLISTER PACK in 1 CARTON (10144-342-60) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
10144-0342-92 23 BLISTER PACK in 1 CARTON (10144-342-92) / 4 CAPSULE in 1... Inbrija Merz Pharmaceuticals, LLC 2018-12-22
Observed labelers: Merz Pharmaceuticals, LLC (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.